KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) FCF Payout Ratio (2016 - 2025)

Gilead Sciences' FCF Payout Ratio history spans 12 years, with the latest figure at 0.31 for Q4 2025.

  • For Q4 2025, FCF Payout Ratio fell 9.69% year-over-year to 0.31; the TTM value through Dec 2025 reached 0.42, up 10.31%, while the annual FY2025 figure was 0.42, 10.95% up from the prior year.
  • FCF Payout Ratio reached 0.31 in Q4 2025 per GILD's latest filing, up from 0.25 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 1.38 in Q2 2025 to a low of 0.23 in Q3 2024.
  • Average FCF Payout Ratio over 5 years is 0.49, with a median of 0.42 recorded in 2023.
  • The largest YoY upside for FCF Payout Ratio was 88.65% in 2024 against a maximum downside of 59.83% in 2024.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.3 in 2021, then rose by 29.34% to 0.38 in 2022, then increased by 26.78% to 0.49 in 2023, then dropped by 28.51% to 0.35 in 2024, then decreased by 9.69% to 0.31 in 2025.
  • Per Business Quant, the three most recent readings for GILD's FCF Payout Ratio are 0.31 (Q4 2025), 0.25 (Q3 2025), and 1.38 (Q2 2025).